ARTICLE | Company News
Evotec, Jain Foundation deal
November 17, 2014 8:00 AM UTC
Evotec and Jain extended and expanded their 2012 deal to develop a cell-based high throughput screening assay using dysferlin ( DYSF)-deficient cells to identify compounds to treat dysferlinopathy. U...